Berberine alone or combined with cisplatin may induce ovarian cancer cells to arrest at the G0/G1 phase and enhance the activity of cell death-associated proteins, including caspase-8 and caspase-3, thereby promoting apoptosis and necrosis (96). The gene discussed is CASP3; the disease is ovarian cancer.